Four new us patents granted to Acrux for transdermal drug delivery
26th Sep 2005, 20:01 GMT
Acrux Limited (ASX: ACR), the Australian pharmaceutical company that specialises in products delivering therapeutic drugs through the skin, today announced that it has been granted four more US patents relating to its transdermal drug delivery technology.
Latest news from EurekAlert! - Policy and Ethics:
- Bariatric surgery complication rates high in some hospitals, new HealthGrades ratings and study show
- A company's reputation is what gets fried when its books get cooked
- Sensor networks protect containers, navigate robots
- Queen's Surveillance Project benchmarks global attitudes about being watched
- Elderly, ill men get unneeded prostate cancer screenings
- Want fair and affordable health insurance for the uninsured? Ask the public to design it
- New book by University of Minnesota historian exposes Turkey's responsibility in Armenian genocide
- The Last Great Wilderness
- 'Moral clarity' espoused in debate over health-care reform
- RAND study says US should greatly expand efforts